title: The year's new drugs & biologics 2015: Part I.
abstract: Nearly 100 new drugs and biologics, including important new line extensions, were approved or launched for the first time globally in 2015. These products are covered in depth in part I of our annual review of the pharma and biotech industry.
authors.affiliation: Thomson Reuters, Barcelona, Spain. ann.graul@thomsonreuters.com.
authors.forename: A I
authors.initials: AI
authors.lastname: Graul
authors.affiliation: Thomson Reuters, Barcelona, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Cruces
authors.affiliation: Thomson Reuters, Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Stringer
mesh_terms: D001688:Biological Products; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D004364:Pharmaceutical Preparations
chemical_list: D001688:Biological Products; D004364:Pharmaceutical Preparations
keywords: First-in-class drugs; Line extensions; New drug approvals; New drug launches